BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10457414)

  • 1. Immunosuppression due to MACOP-B does not seem to cure the antiphospholipid syndrome.
    Stefani PM; Pietrogrande F; Sartori R; Girolami A
    Haematologica; 1999 Aug; 84(8):751-2. PubMed ID: 10457414
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
    Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
    Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
    [No Abstract]   [Full Text] [Related]  

  • 5. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis.
    Martelli MP; Martelli M; Pescarmona E; De Sanctis V; Donato V; Palombi F; Todisco E; Rendina EA; Pau FM; Mandelli F
    Ann Oncol; 1998 Sep; 9(9):1027-9. PubMed ID: 9818079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of different chemotherapy programs, indications for surgery and radiotherapy in primary mediastinal B-cell lymphosarcoma].
    Dzhumabaeva BT; Kremenetskaia AM; Gotman LN; Shavlokhov VS; Kaplanskaia IB; Kravchenko SK; Vishnevskaia ES; Gemdzhian EG; Frank GA
    Ter Arkh; 2005; 77(8):78-81. PubMed ID: 16206611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
    Takács I; Eros N; Bene I; Bozsó F; Tordai L; Károlyi Z; Radványi G; Matolcsy A
    Ann Hematol; 2004 Sep; 83(9):608-10. PubMed ID: 15205915
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients.
    Casadei B; Argnani L; Morigi A; Lolli G; Broccoli A; Pellegrini C; Nanni L; Stefoni V; Coppola PE; Carella M; Cavo M; Zinzani PL
    Ann Hematol; 2021 Sep; 100(9):2261-2268. PubMed ID: 33305333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gall bladder perforation in response to chemotherapy in a patient with a histiocytic lymphoma.
    Schaafsma MR; Peters WG; Tham RT; Alleman MJ; Willemze R
    Neth J Med; 1988 Aug; 33(1-2):78-82. PubMed ID: 2469970
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical problems in patients with malignancy: case 2. Wernicke's encephalopathy: an unusual acute neurologic complication of lymphoma and its therapy.
    Turner JE; Alley JG; Sharpless NE
    J Clin Oncol; 2004 Oct; 22(19):4020-2. PubMed ID: 15459227
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpectedly high toxicity of MACOP-B in young patients with low grade lymphoma.
    Arranz R; Pérez G; Steegmann JL; Cámara R; Tomás JF; Figuera A; Vazquez L; Fernández-Rañada JM
    Am J Hematol; 1991 Sep; 38(1):75-6. PubMed ID: 1716853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
    Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
    Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to improve the efficacy of R-CHOP for indolent B-cell lymphoma?].
    Tobinai K
    Rinsho Ketsueki; 2012 Jun; 53(6):609-17. PubMed ID: 22790636
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
    Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
    Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive sclerodermoid skin changes--quiz case.
    Dacso MM; Petitt MS; Berlingeri-Ramos AC; Kelly BC
    Arch Dermatol; 2012 Feb; 148(2):247-52. PubMed ID: 22351831
    [No Abstract]   [Full Text] [Related]  

  • 18. Unusual lymphoma manifestations: case 2. Myocardial lymphoma presenting as atrial flutter.
    Thompson MA; Harker-Murray A; Locketz AJ; Chareonthaitawee P
    J Clin Oncol; 2004 Feb; 22(3):558-60. PubMed ID: 14752079
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete remission by chemotherapy in stage IE-IIE primary gastric lymphoma.
    Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T
    Hepatogastroenterology; 2007 Jun; 54(76):1285-8. PubMed ID: 17629090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.